We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Efficacy and Safety Information Sample Clauses

Efficacy and Safety Information. Endo shall furnish Vernalis with efficacy and safety information reasonably requested by Vernalis to assist Vernalis in promoting the Product to Target Healthcare Professionals in the USA, including without limitation relevant clinical and safety data included in the NDA for the Product and additional information, if any, related to the efficacy and safety profile of the Product since the transfer of the NDA to Endo from Vernalis. Except for that information that is to be disclosed to Target Healthcare Professionals in connection with conducting Product Details, such information shall be treated as Confidential Information of Endo pursuant to
Efficacy and Safety InformationEach party shall furnish the other with efficacy and safety information in its possession as reasonably requested to assist each party in the performance of its obligations under this Agreement, including without limitation relevant clinical and safety data included in the NDA (or comparable filing in the Territory) for the Products and additional information, if any, related to the efficacy and safety profile of the Products. Except for that information that is to be disclosed to OB/GYN's in connection with conducting details, such information shall be treated as Confidential and Proprietary Information pursuant to Section 8 of this Agreement and shall not be disclosed to third parties without the prior written approval or direction of the party owning such Confidential and Proprietary Information.
Efficacy and Safety Information. Bayer shall furnish Onyx with efficacy and safety information reasonably requested by Onyx to assist Onyx in promoting the Co-Promotion Collaboration Product to Target Healthcare Professionals in the United States, including without limitation relevant clinical and safety data included in the NDA for the Co- Promotion Collaboration Product and additional information, if any, related to the efficacy and safety profile of the Co-Promotion Collaboration Product.
Efficacy and Safety Information. GENENTECH shall furnish the ------------------------------- INTEGRILIN PARTNERS with efficacy and safety information reasonably requested by the INTEGRILIN PARTNERS to assist it in promoting the GENENTECH Products in the Territory, including, without limitation, summaries of relevant clinical and safety data [*] for the GENENTECH [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Efficacy and Safety InformationEach party shall furnish the other with efficacy, safety and other information in its possession, or that may come into its possession, as reasonably requested to assist each party in the performance of its obligations under this Agreement, including relevant clinical and safety data included in the applicable ANDA for the Anusol Cream.
Efficacy and Safety Information. BMS shall xxxxxxx Xxxxx with efficacy and safety information reasonably requested by Xxxxx to assist it in promoting the Product in the Territory, including, without limitation, summaries of relevant clinical and safety data included in the NDA for the Product and summaries of information related to the efficacy and safety profile of the Product since its approval by the FDA. In connection therewith, except as otherwise specifically provided in this Article 9, BMS will provide Xxxxx in a timely manner with copies of all Medwatch and or CIOMS-I reports submitted by BMS with respect to the Product, (i.e., within seven (7) days of submission for Serious Adverse Events and on a monthly basis for Non-Serious Adverse Events.) Raw data or databases will not be made available to Xxxxx.
Efficacy and Safety Information. Galderma shall furnish PhotoMedex with efficacy and safety information reasonably requested by PhotoMedex to assist PhotoMedex in promoting the Product, including without limitation relevant clinical and safety data included in the NDA for the Product and additional information, if any, related to the efficacy and safety profile of the Product since the Product’s approval by the FDA.
Efficacy and Safety Information. King will furnish Inyx with efficacy and safety information reasonably requested by Inyx to assist Inyx in promoting the Products to Physicians in the Territory, including relevant clinical and safety data included in the NDA for the Products and additional information, if any, related to the efficacy and safety profile of the Products since the Products’ approval by the applicable Regulatory Authority. King will also provide Inyx with updates to annual reports required to be delivered by King pursuant to this Agreement. Except for that information that is to be disclosed to Physicians in connection with conducting Details, such information will be treated as the Confidential Information of King.
Efficacy and Safety Information. Nastech shall furnish LICENSEE with such efficacy and safety information as is required by law and otherwise is in the possession or control of Nastech to assist LICENSEE in the marketing, promotion, sale and distribution of the Product.
Efficacy and Safety Information. During the Copromotion Period King shall furnish Wyeth with efficacy and safety information reasonably requested by Wyeth to assist Wyeth in promoting the Product(s) to Physicians in the Territory, including without limitation relevant clinical and safety data included in the NDA for the Product(s) and additional information, if any, related to the efficacy and safety profile of the Product(s) since the Product’s approval by the FDA. Except for that information that is to be disclosed to Physicians in connection with conducting Details, such information shall be treated as confidential and proprietary information pursuant to Section 12 of this Agreement and shall not be disclosed to third parties without King’s prior written approval or direction.